Company Filing History:
Years Active: 2014-2015
Title: Innovations of Isabelle Le Roy
Introduction
Isabelle Le Roy is a notable inventor based in Frouzins, France. She has made significant contributions to the field of human therapy through her innovative work on potassium channel blockers. With a total of three patents to her name, her research focuses on the development of novel compounds that have therapeutic applications.
Latest Patents
Isabelle Le Roy's latest patents include "Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy." This invention concerns derivatives of heteroarylsulfonamides, particularly as blockers of Kv potassium channels, specifically Kv1.5, Kv4.3, and Kv11.1. The compounds are designed for clinical therapy and have a general formula that includes various substituents and functional groups. Another significant patent is "Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans." This invention relates to diarylpyridazinone derivatives that also block the potassium Kv channels and are intended for therapeutic use in humans.
Career Highlights
Throughout her career, Isabelle has worked with prominent companies such as Pierre Fabre Medicament and Pierre Fabre Médicament. Her work in these organizations has allowed her to advance her research and contribute to the development of innovative therapeutic solutions.
Collaborations
Isabelle has collaborated with notable colleagues, including Elisabeth Dupont-Passelaigue and Christophe Pignier. These collaborations have enriched her research and expanded the impact of her inventions.
Conclusion
Isabelle Le Roy is a distinguished inventor whose work on potassium channel blockers has the potential to significantly impact human therapy. Her innovative patents and collaborations highlight her contributions to the field of medical research.